Folgen
Katarina Varnas
Katarina Varnas
Zugehörigkeit unbekannt
Bestätigte E-Mail-Adresse bei ki.se
Titel
Zitiert von
Zitiert von
Jahr
Preclinical comparison of osimertinib with other EGFR-TKIs in EGFR-mutant NSCLC brain metastases models, and early evidence of clinical brain metastases activity
P Ballard, JWT Yates, Z Yang, DW Kim, JCH Yang, M Cantarini, K Pickup, ...
Clinical Cancer Research 22 (20), 5130-5140, 2016
6492016
Autoradiographic distribution of serotonin transporters and receptor subtypes in human brain
K Varnäs, C Halldin, H Hall
Human brain mapping 22 (3), 246-260, 2004
3912004
Clinical validation of 18F-AZD4694, an amyloid-β–specific PET radioligand
Z Cselényi, ME Jönhagen, A Forsberg, C Halldin, P Julin, M Schou, ...
Journal of Nuclear Medicine 53 (3), 415-424, 2012
2472012
Regional thinning of the cerebral cortex in schizophrenia: effects of diagnosis, age and antipsychotic medication
R Nesvåg, G Lawyer, K Varnäs, AM Fjell, KB Walhovd, A Frigessi, ...
Schizophrenia research 98 (1-3), 16-28, 2008
2472008
The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models
ST Durant, L Zheng, Y Wang, K Chen, L Zhang, T Zhang, Z Yang, ...
Science advances 4 (6), eaat1719, 2018
2322018
Effect of the myeloperoxidase inhibitor AZD3241 on microglia: a PET study in Parkinson’s disease
A Jucaite, P Svenningsson, JO Rinne, Z Cselenyi, K Varnäs, P Johnström, ...
Brain 138 (9), 2687-2700, 2015
1862015
Distribution of 5-HT7 receptors in the human brain: a preliminary autoradiographic study using [3H] SB-269970
K Varnäs, DR Thomas, E Tupala, J Tiihonen, H Hall
Neuroscience letters 367 (3), 313-316, 2004
1442004
Autoradiographic mapping of 5-HT1B and 5-HT1D receptors in the post mortem human brain using [3H] GR 125743
K Varnäs, H Hall, P Bonaventure, G Sedvall
Brain research 915 (1), 47-57, 2001
1382001
Preclinical comparison of the blood–brain barrier permeability of osimertinib with other EGFR TKIs
N Colclough, K Chen, P Johnström, N Strittmatter, Y Yan, GL Wrigley, ...
Clinical Cancer Research 27 (1), 189-201, 2021
1262021
Detection of amyloid in Alzheimer’s disease with positron emission tomography using [11C]AZD2184
S Nyberg, ME Jönhagen, Z Cselényi, C Halldin, P Julin, H Olsson, ...
European journal of nuclear medicine and molecular imaging 36, 1859-1863, 2009
992009
Distribution of 5-HT4 receptors in the postmortem human brain—an autoradiographic study using [125I] SB 207710
K Varnäs, C Halldin, VW Pike, H Hall
European Neuropsychopharmacology 13 (4), 228-234, 2003
992003
The 5-HT1B receptor-a potential target for antidepressant treatment
M Tiger, K Varnäs, Y Okubo, J Lundberg
Psychopharmacology 235 (5), 1317-1334, 2018
872018
Kinetic analysis and test-retest variability of the radioligand [11C](R)-PK11195 binding to TSPO in the human brain - a PET study in control subjects
A Jučaite, Z Cselényi, A Arvidsson, G Åhlberg, P Julin, K Varnäs, ...
EJNMMI research 2, 1-13, 2012
852012
Quantitative Analysis of [11C]AZ10419369 Binding to 5-HT1B Receptors in Human Brain
K Varnäs, S Nyberg, C Halldin, A Varrone, A Takano, P Karlsson, ...
Journal of Cerebral Blood Flow & Metabolism 31 (1), 113-123, 2011
832011
[11C] AZ10419369: a selective 5-HT1B receptor radioligand suitable for positron emission tomography (PET). Characterization in the primate brain
ME Pierson, J Andersson, S Nyberg, DJ McCarthy, SJ Finnema, K Varnäs, ...
Neuroimage 41 (3), 1075-1085, 2008
822008
Regional expression of 5‐HT1B receptor mRNA in the human brain
K Varnäs, YL Hurd, H Hall
Synapse 56 (1), 21-28, 2005
622005
Synthesis and biological evaluation of technetium (III) mixed-ligand complexes with high affinity for the cerebral 5-HT1A receptor and the alpha1-adrenergic receptor
A Drews, HJ Pietzsch, R Syhre, S Seifert, K Varnäs, H Hall, C Halldin, ...
Nuclear medicine and biology 29 (4), 389-398, 2002
582002
PET imaging of [11C]PBR28 in Parkinson’s disease patients does not indicate increased binding to TSPO despite reduced dopamine transporter binding
K Varnäs, Z Cselényi, A Jucaite, C Halldin, P Svenningsson, L Farde, ...
European journal of nuclear medicine and molecular imaging 46, 367-375, 2019
532019
A positron emission tomography study in healthy volunteers to estimate mGluR5 receptor occupancy of AZD2066—estimating occupancy in the absence of a reference region
M Kågedal, Z Cselényi, S Nyberg, P Raboisson, L Ståhle, P Stenkrona, ...
Neuroimage 82, 160-169, 2013
492013
A PET study in healthy subjects of brain exposure of 11C-labelled osimertinib – A drug intended for treatment of brain metastases in non-small cell lung cancer
A Varrone, K Varnäs, A Jucaite, Z Cselényi, P Johnström, M Schou, ...
Journal of Cerebral Blood Flow & Metabolism 40 (4), 799-807, 2020
472020
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20